AbbVie Supports Students Living with Immune-Mediated Diseases

Quote2 1651089652581 Hr
Courtesy of AbbVie

AbbVie has announced the 2022-2023 recipients of the AbbVie Immunology Scholarship, which provides financial support to students living with chronic, immune-mediated diseases pursuing higher education in the U.S.

The scholarship seeks to empower students as they pursue a degree and a life not defined by their diseases.

"While living with chronic, immune-mediated diseases that are often difficult to manage, recipients of the AbbVie Immunology Scholarship have made an impact in their communities and exemplified determination to overcome challenges," said Patrick Horber, MD, president, U.S. Immunology, AbbVie. "As a trusted leader in immunology, AbbVie is proud to help support these students' academic journeys as they continue to take on inspiring challenges and pursue their ambitions to make a difference in their communities."

AbbVie received over 1,000 applications from students with diverse backgrounds, perspectives and disease experiences throughout the U.S. Qualified applicants were selected based on academic performance, ability to serve as a positive role model in their respective communities, essay submission and recommendation letters.

Since its launch in 2016, the AbbVie Immunology Scholarship has helped over 300 students living with chronic, immune-mediated diseases pursue higher education in the U.S. Students living with diseases across dermatology, gastroenterology and rheumatology and seeking an associate, bachelor's, master's or doctorate degree are eligible to apply for the scholarship.

If you know any students interested and eligible for the 2023-2024 AbbVie Immunology Scholarship, suggest they sign up to be notified when the application period opens. 

More in News